Special notice
Notice of Contract Award - Orexo US, Inc.
BARDA-BAA-OrexoNotice
Office of Assistant Secretary for Preparedness and Response, Barda - Aspr / Daappo / Barda DCMA. Research and Development in Biotechnology (except Nanobiotechnology).
Response deadline
September 24, 2025 at 5:00 PM EDT
Closed 357 days ago. Posted September 26, 2025. Scheduled to archive October 9, 2025.
Description
As published on SAM.gov.
Award Notice for Orexo US, Inc. (Contract 75A50125C00010). Clinical development of OX390 (atipamezole) as an ?2 agonist reversal agent for human use to counteract the sedative effects of xylazine, medetomidine, and other ?2 agonists that are increasingly found in combination with IMF.
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
September 26, 2025
Special notice
Due September 24, 2025 at 5:00 PM EDT. SAM.gov, notice 2f2165fde1f3420891121bb88d554782
Points of contact
- Jonathan Gonzalez, Contracting OfficerJonathan.Gonzalez@hhs.gov2023817248
- Joann Kambaja, Contract SpecialistJoann.Kambaja@hhs.gov202-913-5470
Also open from this buyer
- Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & ResponseSolicitationNAICS 541714Washington, DC75A50126R00001_RFP_NPIVS_27Closes in 65 daysNov 20
- BARDA DRIVe EZ-BAA (EZBAA - 22-100-SOL-00003)SolicitationNAICS 541714DRIVeEZBAA22100SOL00003Closes in 397 daysOct 18, 2027